Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?

Objectives Antimicrobial resistance (AMR) is a significant global health threat with substandard and falsified (SF) antibiotics being neglected contributing factors. With their relationships poorly understood, more research is needed in order to determine how interventions to reduce SF antibiotics s...

Full description

Bibliographic Details
Main Authors:	Paul N Newton, Céline Caillet, Vayouly Vidhamaly, Guillermo A Zabala, Khonsavath Bellingham, Phonepasith Boupha, Kem Boutsamay
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-08-01
Series:	BMJ Global Health
Online Access:	https://gh.bmj.com/content/7/8/e008587.full

Similar Items

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
by: Zabala, GA, et al.
Published: (2022)

Evaluation of portable devices for medicine quality screening: Lessons learnt, recommendations for implementation, and future priorities.
by: Céline Caillet, et al.
Published: (2021-09-01)

A comparative field evaluation of six medicine quality screening devices in Laos.
by: Céline Caillet, et al.
Published: (2021-09-01)

Multiphase evaluation of portable medicines quality screening devices.
by: Céline Caillet, et al.
Published: (2021-09-01)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
by: Sean Cavany, et al.
Published: (2023-10-01)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
by: Cavany, S, et al.
Published: (2023)

The quality of veterinary medicines and their implications for One Health
by: Paul N Newton, et al.
Published: (2022-08-01)

Trade in substandard and falsified medicines
by: Hagen, N, et al.
Published: (2022)

Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020-03-01)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
by: Tabernero, P, et al.
Published: (2022)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
by: Tabernero, P, et al.
Published: (2019)

How to achieve international action on falsified and substandard medicines.
by: Attaran, A, et al.
Published: (2012)

Substandard and falsified antimicrobials in selected east African countries: A systematic review
by: Addisu Afrassa Tegegne, et al.
Published: (2024-01-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review.
by: Addisu Afrassa Tegegne, et al.
Published: (2024-01-01)

The economic impact of substandard and falsified antimalarial medications in Nigeria.
by: Sarah M Beargie, et al.
Published: (2019-01-01)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
by: Robin Rojas-Cortés
Published: (2020-10-01)

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
by: Kathryn D. Jackson, et al.
Published: (2020-07-01)

Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study
by: Hui-Han Chen, et al.
Published: (2021-03-01)

The concept of substandard (falsified and poor quality) industrial products and its types
by: K. A. Utarov, et al.
Published: (2022-09-01)

The concept of substandard (falsified and poor quality) industrial products and its types
by: K. A. Utarov, et al.
Published: (2022-09-01)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
by: Elizabeth Pisani, et al.
Published: (2021-08-01)

Technologies for detecting falsified and substandard drugs in low and middle-income countries.
by: Stephanie Kovacs, et al.
Published: (2014-01-01)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
by: Yusuf Hassan Wada, et al.
Published: (2022-06-01)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
by: Faris El-Dahiyat, et al.
Published: (2021-10-01)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
by: Waleed M. Sweileh
Published: (2021-09-01)

Mobile apps for detecting falsified and substandard drugs: A systematic review.
by: Agustín Ciapponi, et al.
Published: (2021-01-01)

Exploring pharmacists' perspectives about substandard and falsified medical products through interviews
by: A. Persson, et al.
Published: (2024-03-01)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
by: Tamara Akpobolokemi, et al.
Published: (2022-01-01)

The quality of antiretroviral medicines: an uncertain problem
by: Paul N Newton, et al.
Published: (2023-03-01)

The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products
by: Naughton, B
Published: (2018)

Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
by: Hauk, C, et al.
Published: (2021)

A comparative field evaluation of six medicine quality screening devices in Laos
by: Caillet, C, et al.
Published: (2021)

Evaluation of portable devices for medicine quality screening: Lessons learnt, recommendations for implementation, and future priorities
by: Caillet, C, et al.
Published: (2021)

Multiphase evaluation of portable medicines quality screening devices
by: Caillet, C, et al.
Published: (2021)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.
by: Colleen R Higgins, et al.
Published: (2023-01-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
by: Colleen R. Higgins, et al.
Published: (2023-01-01)

The quality of veterinary medicines and their implications for One Health
by: Vidhamaly, V, et al.
Published: (2022)

Uncovering the Quality Deficiencies with Potentially Harmful Effects in Substandard and Falsified PDE-5 Inhibitors Seized by Belgian Controlling Agencies
by: Celine Vanhee, et al.
Published: (2023-07-01)

Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy.
by: Graham Lawson, et al.
Published: (2018-01-01)

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
by: Albert Petersen, et al.
Published: (2017-01-01)